88 related articles for article (PubMed ID: 18060817)
1. The role of collagenases in experimental pulmonary fibrosis.
Ouchi H; Fujita M; Ikegame S; Ye Q; Inoshima I; Harada E; Kuwano K; Nakanishi Y
Pulm Pharmacol Ther; 2008; 21(2):401-8. PubMed ID: 18060817
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
3. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of pulmonary fibrosis by doxycycline: an experiment with mice].
Huang YH; Li Y; Shang Y; Ouyang ZG; Zhen YS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(3):182-6. PubMed ID: 16638326
[TBL] [Abstract][Full Text] [Related]
5. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis.
Madtes DK; Elston AL; Kaback LA; Clark JG
Am J Respir Cell Mol Biol; 2001 May; 24(5):599-607. PubMed ID: 11350830
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin-induced pulmonary fibrosis.
Yaguchi T; Fukuda Y; Ishizaki M; Yamanaka N
Pathol Int; 1998 Dec; 48(12):954-63. PubMed ID: 9952339
[TBL] [Abstract][Full Text] [Related]
7. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y
Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
[TBL] [Abstract][Full Text] [Related]
8. Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis.
Manoury B; Nénan S; Guénon I; Lagente V; Boichot E
Int Immunopharmacol; 2007 Jul; 7(7):900-11. PubMed ID: 17499192
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
[TBL] [Abstract][Full Text] [Related]
10. TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung.
Manoury B; Caulet-Maugendre S; Guénon I; Lagente V; Boichot E
Int J Immunopathol Pharmacol; 2006; 19(3):471-87. PubMed ID: 17026855
[TBL] [Abstract][Full Text] [Related]
11. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
[TBL] [Abstract][Full Text] [Related]
12. Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis.
Kim JY; Choeng HC; Ahn C; Cho SH
Yonsei Med J; 2009 Feb; 50(1):68-77. PubMed ID: 19259351
[TBL] [Abstract][Full Text] [Related]
13. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis.
Manoury B; Nenan S; Leclerc O; Guenon I; Boichot E; Planquois JM; Bertrand CP; Lagente V
Respir Res; 2005 Jan; 6(1):11. PubMed ID: 15663794
[TBL] [Abstract][Full Text] [Related]
14. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
15. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
[TBL] [Abstract][Full Text] [Related]
16. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin.
Betsuyaku T; Fukuda Y; Parks WC; Shipley JM; Senior RM
Am J Pathol; 2000 Aug; 157(2):525-35. PubMed ID: 10934155
[TBL] [Abstract][Full Text] [Related]
17. [Effects of metalloproteinases on pulmonary fibrosis by bleomycin in rats].
Liu X; Xu S; He B; Tan W
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):98-100. PubMed ID: 11820951
[TBL] [Abstract][Full Text] [Related]
18. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor NRF2 protects against pulmonary fibrosis.
Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
[TBL] [Abstract][Full Text] [Related]
20. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
